Author:
Crommelin Daan J. A.,de Vlieger Jon S. B.,Weinstein Vera,Mühlebach Stefan,Shah Vinod P.,Schellekens Huub
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. FDA, Drug Price Competition and Patent Term Restoration Act of 1984 PL 98–417 (Sept. 24, 1984) Available via htpp://www.fda.gov Accessed 3 Dec 2012.
2. Schellekens H, Klinger E, Mühlebach S, Brin JF, Storm G, Crommelin DJA. The therapeutic equivalence of complex drugs. Regul Toxicol Pharmacol. 2011;59:176–83.
3. Directive 2001/83/EC, http://www.emea.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004481.pdf . Accessed 3 Dec 2012.
4. Weise M, Bielsky MC, De Smet K, Ehmann F, Ekman N, Narayanan G, et al. Biosimilars—why terminology matters. Nat Biotechnol. 2011;29(8):690–3.
5. Directive 2010/84/EU, http://ec.europa.eu/health/files/eudralex/vol-1/dir_2010_84/dir_2010_84_en.pdf . Accessed 3 Dec 2012.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献